Skip to main content
Caplight Logo









Everads Therapy

Everads Therapy

Private
Tel AvivHealthcare & Life Scienceshttps://www.everads-therapy.com/

Last Round

Grant

Feb 1, 2020

Total Funding Raised

$140,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Everads Therapy is a biotechnology company developing a novel delivery technology to treat retinal diseases via suprachoroidal administration.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

suprachoroidal deliverydrug delivery platformSCS deliveryretinal disease therapyocular drug deliverygene therapy deliverycell therapy deliverynon-surgical deliverydrug delivery licensingmedical device platformsuprachoroidal spaceoffice-based procedureposterior segment deliveryclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Everads Therapy Comparables

Compare Everads Therapy with similar companies based on industry and business-model similarity.

Everads Therapy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Clearside Biomedical, Inc.
82%
West Pharmaceutical Services, Inc.
69%
Carl Zeiss Meditec AG
63%

Everads Therapy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 1, 2020
AcceleratorJan 1, 2017

Key People

Founding team and executive leadership

Yonatan Cohavi

Chief Financial Officer

Executive Team

Everads Therapy Investors

Notable investors and investment history

Everads Therapy investors
InvestorRounds
European Innovation Council FundGrant
Israel Innovation AuthorityGrant
RAD BioMedAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 33% MoM.

  • Jul 27, 2026

    Monthly visitors grew 104% MoM, reaching 1.6K.

Everads Therapy Filings

Explore SEC and related filing metadata, where available.

Everads Therapy filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Everads Therapy's valuation, stock price, and market status.

Is Everads Therapy a public or private company?

Everads Therapy is a private company.

What is the current stock price of Everads Therapy?

Everads Therapy is a private company with no public stock price. No recent secondary market data is available.

How much is Everads Therapy worth (valuation)?

Valuation information for Everads Therapy is not publicly available.

Can I buy Everads Therapy stock?

Everads Therapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Everads Therapy's last funding round?

Everads Therapy's most recent funding round was Grant on February 1, 2020.

Who are the main investors in Everads Therapy?

Key investors in Everads Therapy include European Innovation Council, Israel Innovation Authority, RAD BioMed.

Will Everads Therapy IPO soon?

No public IPO plans have been announced for Everads Therapy.

How can I track Everads Therapy secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Everads Therapy's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTel Aviv
Employee Range6
Year Founded2017
Last FundingFeb 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?